Diabetes Group Prenatal Care

Overview

The investigators primary objective is to conduct a pilot randomized trial to determine the effect of group prenatal care on self-care activities in women with diabetes.

Full Title of Study: “Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: July 6, 2017

Detailed Description

Long term, the investigators aim to test the central hypothesis that group prenatal care, compared to traditional prenatal care, will improve glycemic control and, ultimately, maternal and neonatal outcomes in women with type 2 and gestational diabetes. The objective of this proposal is to conduct a pilot randomized trial to determine the effect of group prenatal care on self-care activities, which have been associated with improved glycemic control, in women with diabetes.

Interventions

  • Behavioral: Group prenatal care
    • Women will receive their prenatal care in a group rather than in the 1:1 traditional manner.

Arms, Groups and Cohorts

  • No Intervention: Routine Prenatal Care
    • Subjects randomized to routine care will receive their care in the usual diabetic clinic attended by residents and faculty. They will receive consultation with the diabetes educator at diagnosis and as needed. Patients are seen every 2 weeks (or more by provider discretion) until 37 weeks and weekly until delivery. Visits are 10-15 minutes and focus on routine screening tests and review of blood sugar logs/medication titration. Each subject’s medical chart will be reviewed for demographics, antenatal management, maternal and neonatal outcomes.
  • Experimental: Group prenatal care
    • Group visits will be held every 2 weeks in a continuous cycle through a four session curriculum. Women will have weekly visits beginning at 37 weeks with traditional prenatal visits on the weeks when the group does not meet. Groups of 4-12 women will meet for two hour visits and much of that time will be spent on pregnancy, behavioral health, diabetes and nutrition education. Groups will be co-facilitated by 2 CenteringPregnancy trained providers at each site and an obstetric provider. Women may be instructed to have additional visits in the traditional clinic at the discretion of the obstetric provider.

Clinical Trial Outcome Measures

Primary Measures

  • effect of group prenatal care on maternal diabetes self-care activities as measured Diabetes Self-Care Activities Measure
    • Time Frame: 37-39 weeks gestation
    • Determine the effect of group prenatal care on maternal diabetes self-care activities as measured by the Diabetes Self-care Activities Measure and confirmed by percentage of recommended blood glucose values completed on logs since initial study visit.

Secondary Measures

  • effect of group prenatal care on perinatal mood as measured by Edinburgh Postnatal Depression Scale
    • Time Frame: baseline and 4-12 weeks postpartum
    • Determine the effect of group prenatal care on perinatal mood as measured by the Edinburgh Postnatal Depression Scale
  • effect of group prenatal care on perceived social support as assessed by the Social Support Scale
    • Time Frame: 37-39 weeks
    • Determine the effect of group prenatal care on perceived social support through the Social Support Scale
  • Birthweight
    • Time Frame: delivery admission
    • Determine the effect of group prenatal care on birthweight
  • Gestational age at delivery
    • Time Frame: delivery admission
    • Determine the effect of group prenatal care on preterm delivery
  • Mean 3rd trimester fasting blood glucose
    • Time Frame: baseline through delivery
    • Determine the effect of group prenatal care on maternal glycemic control through mean 3rd trimester fasting glucose
  • Breastfeeding
    • Time Frame: 4-12 weeks postpartum
    • Determine the effect of group prenatal care on initiating breastfeeding
  • Contraception
    • Time Frame: 4-12 weeks postpartum
    • Determine the effect of group prenatal care on initiating contraception

Participating in This Clinical Trial

Inclusion Criteria

  • English (WUMC) or Spanish speaking (DH)
  • Type 2 White's Class B diabetes OR gestational diabetes diagnosed by 2-step method < 32 weeks
  • Ability to attend group prenatal visit at specified days and times
  • Willingness to be randomized
  • Randomization at 22 weeks 0 days-32 weeks 0 days
  • Ability to give informed consent

Exclusion Criteria

  • Multiple gestation
  • Major fetal anomaly
  • Serious medical co-morbidity necessitating more care than can be safely provided in group setting, as deemed by medical provider
  • Serious psychiatric illness including schizophrenia necessitating more care than can safely be provided in group setting, as deemed by medical provider

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 50 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Washington University School of Medicine
  • Collaborator
    • Denver Health Medical Center
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Methodius G Tuuli, MD, MPH, Study Director, Assistant Professor, Washington University in St. Louis

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.